Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylene blue in serratus anterior plane block for chronic postsurgical pain after thoracoscopic lung surgery
ChiCTR2500095401Phase 4Not yet recruiting
- Sponsor
- Chengdu Jinniu District People's Hospital
- Start
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of methylene blue in Persistent postsurgical pain (PPSP) (2 arms), sponsored by Chengdu Jinniu District People's Hospital. Primary endpoint: NRS score 6 months after surgery. Planned start Jan 2025; status: not yet recruiting.
02
Drugs
methylene blue
03
Conditions
Persistent postsurgical pain (PPSP)
Beyond the preview
Go deeper on ChiCTR2500095401.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500095401.